GARDEN CITY, NY - Beyond Air, Inc. (NASDAQ:XAIR), a medical device company specializing in the design and development of therapeutic products, has entered into a sales agreement to potentially sell up ...

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) ...

NanoVibronix (NAOV) announced the completion of the acquisition of ENvue Medical Holdings. The company said, “This strategic transaction will ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future ...

The company has a debt-to-equity ratio of 0.48, a current ratio of 1.04 and a quick ... The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as ...

Apollon Wealth Management LLC boosted its stake in Teleflex Incorporated (NYSE:TFX – Free Report) by 10.8% in the fourth quarter, according to the company in its most recent disclosure with the ...

Discover the top seven CBN gummies for sleep on the market, based on overall quality, effectiveness, price, formula, ...

Using the BiovitalsHF software to personalize recommendations got more patients on all four pillars of therapy.